| Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials SL Kristensen, R Rørth, PS Jhund, KF Docherty, N Sattar, D Preiss, ... The lancet Diabetes & endocrinology 7 (10), 776-785, 2019 | 1298 | 2019 |
| Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials N Sattar, MMY Lee, SL Kristensen, KRH Branch, S Del Prato, NS Khurmi, ... The lancet Diabetes & endocrinology 9 (10), 653-662, 2021 | 629 | 2021 |
| Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention … M Lamberts, JB Olesen, MH Ruwald, CM Hansen, D Karasoy, ... Circulation, 2012 Sep 4;126(10):1185-93, 2012 | 539 | 2012 |
| Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention M Lamberts, GH Gislason, JB Olesen, SL Kristensen, ... Journal of the American College of Cardiology 62 (11), 981-989, 2013 | 439 | 2013 |
| Risk related to pre–diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI With ACEI to determine … SL Kristensen, D Preiss, PS Jhund, I Squire, JS Cardoso, B Merkely, ... Circulation: Heart Failure 9 (1), e002560, 2016 | 382 | 2016 |
| SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? N Sattar, J McLaren, SL Kristensen, D Preiss, JJ McMurray Diabetologia 59, 1333-1339, 2016 | 356 | 2016 |
| Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death–a Danish nationwide cohort study SL Kristensen, O Ahlehoff, J Lindhardsen, R Erichsen, GV Jensen, ... PloS one 8 (2), e56944, 2013 | 266 | 2013 |
| Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti‐inflammatory drugs: a D anish real‐world cohort study O Ahlehoff, L Skov, G Gislason, J Lindhardsen, SL Kristensen, L Iversen, ... Journal of internal medicine 273 (2), 197-204, 2013 | 221 | 2013 |
| Cardiovascular outcomes and systemic anti‐inflammatory drugs in patients with severe psoriasis: 5‐year follow‐up of a Danish nationwide cohort O Ahlehoff, L Skov, G Gislason, R Gniadecki, L Iversen, LE Bryld, ... Journal of the European Academy of Dermatology and Venereology 29 (6), 1128-1134, 2015 | 212 | 2015 |
| Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction: a report … SL Kristensen, UM Mogensen, PS Jhund, MC Petrie, D Preiss, S Win, ... Circulation 135 (8), 724-735, 2017 | 200 | 2017 |
| Incidence of hospitalization for heart failure and case-fatality among 3.25 million people with and without diabetes mellitus DA McAllister, SH Read, J Kerssens, S Livingstone, S McGurnaghan, ... Circulation 138 (24), 2774-2786, 2018 | 192 | 2018 |
| Geographic variations in the PARADIGM-HF heart failure trial SL Kristensen, F Martinez, PS Jhund, JL Arango, J Bĕlohlávek, S Boytsov, ... European heart journal 37 (41), 3167-3174, 2016 | 151 | 2016 |
| Comparison of BNP and NT-proBNP in patients with heart failure and reduced ejection fraction R Rørth, PS Jhund, MB Yilmaz, SL Kristensen, P Welsh, AS Desai, ... Circulation: Heart Failure 13 (2), e006541, 2020 | 145 | 2020 |
| Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study SL Kristensen, J Lindhardsen, O Ahlehoff, R Erichsen, M Lamberts, ... Europace, 477-484, 2014 | 130 | 2014 |
| Diabetic cardiomyopathy MMY Lee, JJV McMurray, A Lorenzo-Almorós, SL Kristensen, N Sattar, ... Heart 105 (4), 337-345, 2019 | 114 | 2019 |
| Dementia‐related adverse events in PARADIGM‐HF and other trials in heart failure with reduced ejection fraction JA Cannon, L Shen, PS Jhund, SL Kristensen, L Køber, F Chen, J Gong, ... European journal of heart failure 19 (1), 129-137, 2017 | 112 | 2017 |
| The new pooled cohort equations risk calculator D Preiss, SL Kristensen Canadian journal of Cardiology 31 (5), 613-619, 2015 | 110 | 2015 |
| Dapagliflozin in HFrEF patients treated with mineralocorticoid receptor antagonists: an analysis of DAPA-HF L Shen, SL Kristensen, O Bengtsson, M Böhm, RA de Boer, KF Docherty, ... Heart Failure 9 (4), 254-264, 2021 | 105 | 2021 |
| Psoriasis and new-onset diabetes: a Danish nationwide cohort study U Khalid, PR Hansen, GH Gislason, J Lindhardsen, SL Kristensen, ... Diabetes care 36 (8), 2402-2407, 2013 | 105 | 2013 |
| International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection Fraction SL Kristensen, L Køber, PS Jhund, SD Solomon, JK Kjekshus, ... Circulation, CIRCULATIONAHA. 114.012284, 2014 | 96 | 2014 |
Christian Torp-PedersenProfessor of cardiology and clinical epidemiology, Aalborg University and department of Cardiology在 heart.dk 的电子邮件经过验证
